avoralstat

DRUG2 trials

Sponsors

BioCryst Pharmaceuticals

Conditions

Diabetic Macular Edema (DME)HAEHereditary Angioedema

Phase 1

A Study of Avoralstat In Participants With Diabetic Macular Edema

TerminatedNCT07228559

BioCryst PharmaceuticalsDiabetic Macular Edema (DME)

Start: 2025-10-02End: 2026-04-17Updated: 2026-05-11

Phase 3

Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema

TerminatedNCT02670720

BioCryst PharmaceuticalsHAE, Hereditary Angioedema

Start: 2015-12-31End: 2016-02-29Updated: 2016-02-17